Essentially, we found that sex hormone binding globulin (SHBG) below 33.4 nmol/l was able to predict a high risk for NAFLD in women consulting for PCOS, thus suggesting it as a possible biochemical hallmark of this hepatic disease. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.